APP and Alzheimer disease: To probe the influence of GBLE on the metabolic aberration of AD, the metabolic signatures of WT, APP/PS1, APP/PS1+ Donepezil, and APP/PS1+GBLE groups were compared by focusing on the levels of the above differential metabolites.